⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3148506 | 0.83 | — | — | |
| SCHEMBL1072350 | 0.83 | — | — | |
| SCHEMBL3247394 | 0.83 | — | — | |
| SCHEMBL5838 | 0.83 | — | — | |
| Hydrochloric Acid SCHEMBL17700573 | 0.77 | — | — | |
| SCHEMBL2231323 | 0.77 | — | — | |
| Hydrochloric Acid SCHEMBL22661014 | 0.77 | — | — | |
| Hydrochloric Acid SCHEMBL22661008 | 0.77 | — | — | |
| Hydrochloric Acid SCHEMBL22661010 | 0.77 | — | — | |
| SCHEMBL301443 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112662661-B | Genomic DNA room temperature preservation card and manufacturing method and application thereof | 华南理工大学 | 2023-11-03 | — | — | CN | disclosed |
| CN-115078553-A | Method for detecting various substances in cisplatin raw material by using liquid chromatography | 南京制药厂有限公司 | 2022-09-20 | — | — | CN | disclosed |
| US-9217007-B2 | Platinum anticancer agents | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2015-12-22 | — | — | US | disclosed |
| US-20150196494-A1 | STABILIZED PICOPLATIN ORAL DOSAGE FORM | ACCELERATED PHARMA, INC. | 2015-07-16 | — | — | US | disclosed |
| US-20140155366-A1 | PLATINUM ANTICANCER AGENTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-06-05 | — | — | US | disclosed |
| US-20130202690-A1 | ENCAPSULATED PICOPLATIN | PONIARD PHARMACEUTICALS, INC. (US) | 2013-08-08 | — | — | US | disclosed |
| US-20130183433-A1 | STABILIZED PICOPLATIN ORAL DOSAGE FORM | PONIARD PHARMACEUTICALS, INC. (US) | 2013-07-18 | — | — | US | disclosed |
| US-20120148661-A1 | HIGH BIOAVAILABILITY ORAL PICOPLATIN ANTI-CANCER THERAPY | PONIARD PHARMACEUTICALS, INC. (US) | 2012-06-14 | — | — | US | disclosed |
| EP-2418955-A1 | HIGH BIOAVAILABILITY ORAL PICOPLATIN ANTI-CANCER THERAPY | Poniard Pharmaceuticals, Inc. (US) | 2012-02-22 | — | — | EP | disclosed |
| US-20110033528-A1 | STABILIZED PICOPLATIN ORAL DOSAGE FORM | PONIARD PHARMACEUTICALS, INC. (US) | 2011-02-10 | — | — | US | disclosed |
| US-20100062056-A1 | ENCAPSULATED PICOPLATIN | PONIARD PHARMACEUTICALS, INC. (US) | 2010-03-11 | — | — | US | disclosed |
| EP-2114418-A1 | STABILIZED PICOPLATIN ORAL DOSAGE FORM | Poniard Pharmaceuticals, Inc. (US) | 2009-11-11 | — | — | EP | disclosed |
| EP-2109451-A1 | ENCAPSULATED PICOPLATIN | Poniard Pharmaceuticals, Inc. (US) | 2009-10-21 | — | — | EP | disclosed |
| WO-2008097661-A1 | STABILIZED PICOPLATIN ORAL DOSAGE FORM | PONIARD PHARMACEUTICALS, INC. (US) | 2008-08-14 | — | — | WO | disclosed |
| WO-2008097658-A1 | ENCAPSULATED PICOPLATIN | PONIARD PHARMACEUTICALS, INC. (US) | 2008-08-14 | — | — | WO | disclosed |
| EP-0320960-B1 | AMINO ANTHRACENEDIONES-BIS PLATINUM COMPLEXES, USEFUL AS ANTITUMORAL AGENTS | BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) | 1993-05-12 | — | — | EP | disclosed |
| US-5145848-A | AMINO ANTHRACENEDIONES-BIS PLATINUM COMPLEXES, USEFUL AS ANTITUMORAL AGENTS | BOEHRINGER BIOCHEMIA ROBIN S.P.A. (IT) | 1992-09-08 | — | — | US | disclosed |
| EP-0396588-A1 | AMINO ANTHRACENEDIONES-BIS PLATINUM COMPLEXES, USEFUL AS ANTITUMORAL AGENTS | BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) | 1990-11-14 | — | — | EP | disclosed |
| WO-1989005815-A1 | AMINO ANTHRACENEDIONES-BIS PLATINUM COMPLEXES, USEFUL AS ANTITUMORAL AGENTS | BOEHRINGER BIOCHEMIA ROBIN S.P.A. (IT) | 1989-06-29 | — | — | WO | disclosed |
| EP-0320960-A1 | Amino anthracenediones-bis platinum complexes, useful as antitumoral agents | BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) | 1989-06-21 | — | — | EP | disclosed |